Bolt Biotherapeutics, Inc.
BOLT
$5.44
$0.29385.71%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 47.63% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 47.63% | -- | |||
| Cost of Revenue | -18.45% | -21.57% | |||
| Gross Profit | 28.58% | 31.99% | |||
| SG&A Expenses | -8.08% | -3.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.42% | -14.88% | |||
| Operating Income | 23.98% | 22.68% | |||
| Income Before Tax | 22.45% | 30.72% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 22.45% | 30.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 22.45% | 30.72% | |||
| EBIT | 23.98% | 22.68% | |||
| EBITDA | 24.35% | 23.14% | |||
| EPS Basic | 22.48% | 30.82% | |||
| Normalized Basic EPS | 22.03% | 24.95% | |||
| EPS Diluted | 22.48% | 30.82% | |||
| Normalized Diluted EPS | 22.03% | 24.95% | |||
| Average Basic Shares Outstanding | 0.03% | 0.14% | |||
| Average Diluted Shares Outstanding | 0.03% | 0.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||